JP2022058765A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022058765A5 JP2022058765A5 JP2022010224A JP2022010224A JP2022058765A5 JP 2022058765 A5 JP2022058765 A5 JP 2022058765A5 JP 2022010224 A JP2022010224 A JP 2022010224A JP 2022010224 A JP2022010224 A JP 2022010224A JP 2022058765 A5 JP2022058765 A5 JP 2022058765A5
- Authority
- JP
- Japan
- Prior art keywords
- gel composition
- cosmetic gel
- cosmetic
- permeation enhancer
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 claims 26
- 239000003961 penetration enhancing agent Substances 0.000 claims 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical group CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 claims 6
- 239000000695 adrenergic alpha-agonist Substances 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 210000000744 eyelid Anatomy 0.000 claims 3
- 229960001528 oxymetazoline Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims 2
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 1
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 239000001116 FEMA 4028 Substances 0.000 claims 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims 1
- 229960004853 betadex Drugs 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- IHSPMDXQWYKHOA-UHFFFAOYSA-N dodecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCOC(=O)CN(C)C IHSPMDXQWYKHOA-UHFFFAOYSA-N 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 239000003349 gelling agent Substances 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 1
- 239000006254 rheological additive Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024025657A JP2024057010A (ja) | 2016-01-26 | 2024-02-22 | アルファアドレナリン作動薬の組成物および使用 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662287391P | 2016-01-26 | 2016-01-26 | |
| US62/287,391 | 2016-01-26 | ||
| JP2018558113A JP2019509330A (ja) | 2016-01-26 | 2017-01-26 | アルファアドレナリン作動薬の組成物および使用 |
| PCT/US2017/015181 WO2017132410A1 (en) | 2016-01-26 | 2017-01-26 | Compositions and uses of alpha-adrenergic agents |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558113A Division JP2019509330A (ja) | 2016-01-26 | 2017-01-26 | アルファアドレナリン作動薬の組成物および使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024025657A Division JP2024057010A (ja) | 2016-01-26 | 2024-02-22 | アルファアドレナリン作動薬の組成物および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022058765A JP2022058765A (ja) | 2022-04-12 |
| JP2022058765A5 true JP2022058765A5 (enExample) | 2023-01-19 |
Family
ID=59398678
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558113A Withdrawn JP2019509330A (ja) | 2016-01-26 | 2017-01-26 | アルファアドレナリン作動薬の組成物および使用 |
| JP2022010224A Pending JP2022058765A (ja) | 2016-01-26 | 2022-01-26 | アルファアドレナリン作動薬の組成物および使用 |
| JP2024025657A Pending JP2024057010A (ja) | 2016-01-26 | 2024-02-22 | アルファアドレナリン作動薬の組成物および使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558113A Withdrawn JP2019509330A (ja) | 2016-01-26 | 2017-01-26 | アルファアドレナリン作動薬の組成物および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024025657A Pending JP2024057010A (ja) | 2016-01-26 | 2024-02-22 | アルファアドレナリン作動薬の組成物および使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10828252B2 (enExample) |
| EP (1) | EP3407976A4 (enExample) |
| JP (3) | JP2019509330A (enExample) |
| CN (2) | CN115006537A (enExample) |
| AU (3) | AU2017211793B2 (enExample) |
| CA (1) | CA3012660A1 (enExample) |
| WO (1) | WO2017132410A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120225918A1 (en) | 2011-03-03 | 2012-09-06 | Voom, Llc | Compositions and Methods for Non-Surgical Treatment of Ptosis |
| CN115006537A (zh) | 2016-01-26 | 2022-09-06 | 利维申制药有限公司 | α-肾上腺素能药剂的组合物和用途 |
| JP2020500220A (ja) | 2016-11-15 | 2020-01-09 | クラリア ファーマ ホールディング エービー | 医薬製剤 |
| WO2018170132A1 (en) | 2017-03-14 | 2018-09-20 | University Of Connecticut | Biodegradable pressure sensor |
| GB201709141D0 (en) | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| KR20250099416A (ko) | 2018-03-02 | 2025-07-01 | 퀀텀사이트, 인크. | 조직으로부터 관심 영역의 단리 및 발현 분석을 위한 방법, 조성물, 및 장치 |
| GB201808462D0 (en) | 2018-05-23 | 2018-07-11 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| EP3880754A1 (en) * | 2018-11-15 | 2021-09-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Lactide containing polyester-polyethylene glycol triblock thermoresponsive copolymers |
| US11826495B2 (en) | 2019-03-01 | 2023-11-28 | University Of Connecticut | Biodegradable piezoelectric ultrasonic transducer system |
| US10814001B1 (en) | 2019-05-06 | 2020-10-27 | Rvl Pharmaceuticals, Inc. | Oxymetazoline compositions |
| WO2021183626A1 (en) | 2020-03-10 | 2021-09-16 | University Of Connecticut | Therapeutic bandage |
| US12491290B2 (en) | 2020-06-08 | 2025-12-09 | University Of Connecticut | Biodegradable piezoelectric composite materials |
| CN112791033A (zh) * | 2020-12-30 | 2021-05-14 | 广东蕾琪化妆品有限公司 | 一种新型眼影及其制备方法 |
| US20240225978A1 (en) * | 2021-01-23 | 2024-07-11 | Christine Lynn Bokman | Methods and compositions for pharmacological treatment of blepharoptosis |
| CN113149022B (zh) * | 2021-04-30 | 2022-07-22 | 南昌大学 | 一种二氧化硅@硅酸钙中空纳米球及其制备方法和应用 |
| US11779553B1 (en) * | 2022-11-28 | 2023-10-10 | Atif B. D. Collins | Methods and devices for treatment of eyelid ptosis |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2784127A (en) | 1954-06-02 | 1957-03-05 | Eastman Kodak Co | Plasticized monomeric adhesive compositions and articles prepared therefrom |
| US3598122A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3993073A (en) | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4069307A (en) | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
| US3731683A (en) | 1971-06-04 | 1973-05-08 | Alza Corp | Bandage for the controlled metering of topical drugs to the skin |
| US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| BE795384A (fr) | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
| US3921636A (en) | 1973-01-15 | 1975-11-25 | Alza Corp | Novel drug delivery device |
| US3993072A (en) | 1974-08-28 | 1976-11-23 | Alza Corporation | Microporous drug delivery device |
| US3972995A (en) | 1975-04-14 | 1976-08-03 | American Home Products Corporation | Dosage form |
| US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| US4060084A (en) | 1976-09-07 | 1977-11-29 | Alza Corporation | Method and therapeutic system for providing chemotherapy transdermally |
| US4201211A (en) | 1977-07-12 | 1980-05-06 | Alza Corporation | Therapeutic system for administering clonidine transdermally |
| JPS5562012A (en) | 1978-11-06 | 1980-05-10 | Teijin Ltd | Slow-releasing preparation |
| US4230105A (en) | 1978-11-13 | 1980-10-28 | Merck & Co., Inc. | Transdermal delivery of drugs |
| US4291015A (en) | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| US4444933A (en) | 1982-12-02 | 1984-04-24 | Borden, Inc. | Adhesive cyanoacrylate compositions with reduced adhesion to skin |
| US4757128A (en) | 1986-08-01 | 1988-07-12 | Massachusetts Institute Of Technology | High molecular weight polyanhydride and preparation thereof |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| US5462990A (en) | 1990-10-15 | 1995-10-31 | Board Of Regents, The University Of Texas System | Multifunctional organic polymers |
| US5633009A (en) | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
| BR9306038A (pt) | 1992-02-28 | 1998-01-13 | Univ Texas | Hidrogéis biodegradáveis fotopolimerizáveis como materiais de contato de tecidos e condutores de liberação controlada |
| US5665378A (en) | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
| US5654381A (en) | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
| US6929801B2 (en) | 1996-02-19 | 2005-08-16 | Acrux Dds Pty Ltd | Transdermal delivery of antiparkinson agents |
| US6923983B2 (en) | 1996-02-19 | 2005-08-02 | Acrux Dds Pty Ltd | Transdermal delivery of hormones |
| US5628863A (en) | 1996-06-12 | 1997-05-13 | Lee; Shu-Ken | Pouch producing machine |
| US5869090A (en) | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US6946144B1 (en) | 1998-07-08 | 2005-09-20 | Oryxe | Transdermal delivery system |
| US6611707B1 (en) | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
| US6312612B1 (en) | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
| US6945952B2 (en) | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
| KR20120035220A (ko) * | 2003-01-22 | 2012-04-13 | 센주 세이야꾸 가부시키가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법 |
| US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
| US20090136598A1 (en) * | 2006-04-26 | 2009-05-28 | Aciex, Inc. | Compositions for the Treatment and Prevention of Eyelid Swelling |
| CA2650592A1 (en) * | 2006-04-26 | 2007-11-08 | Aciex, Inc. | Compositions for the treatment and prevention of eyelid swelling |
| US8366677B2 (en) | 2007-08-06 | 2013-02-05 | Transderm, Inc. | Microneedle arrays formed from polymer films |
| MX2010005012A (es) * | 2007-11-08 | 2010-06-23 | Aciex Therapeutics Inc | Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor. |
| US8633181B2 (en) * | 2009-04-09 | 2014-01-21 | Rutgers, The State University Of New Jersey | Treatment of cutaneous hemangioma |
| EP2493475A4 (en) * | 2009-10-30 | 2014-10-29 | Intratus Inc | COSMETIC METHODS AND PREPARATIONS FOR THE PROLONGED RELEASE OF THERAPEUTIC AGENTS IN THE EYE |
| CA2819633C (en) | 2010-12-03 | 2019-04-23 | Allergan, Inc. | Pharmaceutical cream compositions and methods of use |
| US20120225918A1 (en) * | 2011-03-03 | 2012-09-06 | Voom, Llc | Compositions and Methods for Non-Surgical Treatment of Ptosis |
| KR20140074883A (ko) | 2011-07-14 | 2014-06-18 | 알러간, 인코포레이티드 | 옥시메타졸린의 겔 조성물들 및 사용 방법 |
| US20130035338A1 (en) * | 2011-08-05 | 2013-02-07 | Gordon Tang | Eyelid treatment |
| CN104302349B (zh) | 2012-03-16 | 2018-06-05 | 新加坡国立大学 | 制造聚合物微针的新方法 |
| JP2015521910A (ja) | 2012-06-29 | 2015-08-03 | イーエルシー マネージメント エルエルシー | １つ以上の封入された化粧品成分を含む可溶性マイクロニードル |
| WO2015191917A1 (en) | 2014-06-11 | 2015-12-17 | Allergan, Inc. | Stabilized oxymetazoline formulations and their uses |
| US20190000808A1 (en) | 2015-07-13 | 2019-01-03 | Allergan, Inc. | Composition and methods for the treatment of blephopharoptosis |
| CN115006537A (zh) | 2016-01-26 | 2022-09-06 | 利维申制药有限公司 | α-肾上腺素能药剂的组合物和用途 |
-
2017
- 2017-01-26 CN CN202210425295.1A patent/CN115006537A/zh active Pending
- 2017-01-26 AU AU2017211793A patent/AU2017211793B2/en active Active
- 2017-01-26 JP JP2018558113A patent/JP2019509330A/ja not_active Withdrawn
- 2017-01-26 CN CN201780020181.6A patent/CN108883308A/zh active Pending
- 2017-01-26 CA CA3012660A patent/CA3012660A1/en active Pending
- 2017-01-26 WO PCT/US2017/015181 patent/WO2017132410A1/en not_active Ceased
- 2017-01-26 EP EP17744911.3A patent/EP3407976A4/en active Pending
-
2018
- 2018-07-24 US US16/043,725 patent/US10828252B2/en active Active
-
2020
- 2020-10-02 US US17/061,869 patent/US11311476B2/en active Active
- 2020-10-06 US US17/064,327 patent/US11491104B2/en active Active
-
2022
- 2022-01-26 JP JP2022010224A patent/JP2022058765A/ja active Pending
- 2022-09-21 US US17/933,929 patent/US12357561B2/en active Active
- 2022-10-24 AU AU2022257242A patent/AU2022257242A1/en not_active Abandoned
-
2024
- 2024-01-09 AU AU2024200121A patent/AU2024200121B2/en active Active
- 2024-02-22 JP JP2024025657A patent/JP2024057010A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022058765A5 (enExample) | ||
| JP2024057010A5 (enExample) | ||
| US20170112780A1 (en) | Pharmaceutical composition for application to nail | |
| JP2004504333A (ja) | 抗真菌マニキュア組成物 | |
| WO2007102241A1 (ja) | 外用の医薬組成物 | |
| JPWO2019149450A5 (enExample) | ||
| US8986664B2 (en) | Use of monoamine oxidase inhibitors to improve epithelial biology | |
| JP2016512246A5 (enExample) | ||
| WO2007094999A2 (en) | Ungual antifungal compositions | |
| JP2012504616A (ja) | 静電気を防止するための皮膚用製品及びその方法 | |
| AU2005239809A1 (en) | Topical preparation containing ambroxol | |
| JP2945482B2 (ja) | コラーゲンの成熟及び構造の障害の処置のための２，４−ジアミノピリミジン−３−オキシド又はその塩の使用 | |
| JP4359140B2 (ja) | 異常な角質性物質を除去するための製剤 | |
| EP2119431B1 (fr) | Composition contenant l'association de madécassoside et/ou de terminoloside et d'une arginine et/ou l'un de ses sels et/ou l'un de ses dérivés; utilisation de l'association pour induire et/ou stimuler la croissance de ces fibres kératiniques humaines et/ou freiner leur chute. | |
| JP2008538753A5 (ja) | 骨の老化または骨粗しょう症の治療または予防用組成物 | |
| JP2019510730A (ja) | 皮膚化粧用組成物、局所用組成物の製造法、脆弱爪を強化するための方法および組成物の使用 | |
| JP2000355515A (ja) | 化粧料組成物 | |
| JP6894668B2 (ja) | 口腔用組成物 | |
| KR20090067019A (ko) | 필링 화장 재료 및 그의 사용 방법 | |
| JP2005104924A (ja) | 外用医薬組成物 | |
| PL188840B1 (pl) | Zastosowanie preparatu farmaceutycznego zawierającego pochodną hydroksypirydonu | |
| EP3091985B1 (en) | Prostanglandins for topical use in the treatment of migraines. | |
| US20220265543A1 (en) | Cosmetic compositions and uses thereof | |
| JP2008531640A (ja) | セルタコナゾール及びヒドロコルチゾン及び／又は抗菌キノロン化合物を含む抗真菌組成物 | |
| CA1297411C (fr) | Composition pour induire et stimuler la croissance des cheveux et diminuerla chute a base de derives d'alkylene diamino quinazoline |